When compared to seven other anti-diabetic drugs, semaglutide may significantly lower the risk of Alzheimer’s disease in people with type 2 diabetes, according to new research from the Case Western Reserve School of Medicine. These results, which were based on data from a national health records database, were consistent across…

Ten to nineteen year olds had a 55% higher risk of a new type 2 diabetes (T2D) diagnosis one month after a COVID infection, compared with young people diagnosed with a non-COVID respiratory virus. The risk of TD2 diagnosis remained elevated at three months and six months, according to a…

Research led by the Steno Diabetes Center Odense shows that high levels of interleukin (IL)-6 predicted increased risk for obesity-related cancer in newly diagnosed people with type 2 diabetes. Notably, other markers of inflammation, tumor necrosis factor-alpha (TNF-alpha) and high sensitivity C-reactive protein (hsCRP), did not significantly predict cancer risk…

Analyzing PET/CT scans using deep learning algorithms to evaluate images can help identify people at risk of developing type 2 diabetes, according to a study published today in the journal Radiology. The study of more than 32,000 people over the age of 25 in Korea, highlights the value of so-called…

A study of more than 1.5 million people with type 2 diabetes has shown that individuals using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have a significantly lower risk for obesity-associated cancers (OACs) than those using insulin. The findings “provide preliminary evidence of the potential benefit of GLP-1 RAs for cancer…

While semaglutide has been in the biopharma limelight for its impressive effects on weight loss in adults with and without type 2 diabetes, it looks like it could soon be playing second fiddle to another glucagon-like peptide 1 GLP-1 receptor agonist-based medication when it comes to weight loss. A study…

A study of more than 8,000 gut microbiome profiles sampled from people in eight different countries led by researchers based at Harvard University shows abnormal changes in 19 bacterial species are linked to increased risk of developing type 2 diabetes. Of the 19 gut bacteria species identified, five were linked…

Semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist designed to treat type 2 diabetes, is also effective at improving cardiovascular and kidney health and reducing the risk for death in people with type 2 diabetes and kidney disease. As reported in the New England Journal of Medicine, the patients randomized…

An international group of researchers has carried out a large genome-wide association study (GWAS), including over 2.5 million individuals, to study the genetics of type 2 diabetes. As reported in the journal Nature, the team found 1,289 genetic variants linked with type 2 diabetes, mapping to 611 different positions in…

Research from the Mayo Clinic shows that gastric bypass surgery in people with type 2 diabetes results in lasting remission of the disease, even after regaining their weight. The study, published today in the Journal of the American College of Surgeons, shows that gastric bypass patients were more likely to…

Researchers at the University of Granada (UGR), Spain have shown that sclerostin, a bone formation inhibitor protein, is also protective of the cardiovascular health of patients with type 2 diabetes. The research was conducted by the MP20-Biomarkers of Metabolic and Bone Diseases research group at the Biohealth Research Institute in…

A large-scale, community program run by the U.K.’s National Health Service designed to reduce the risk of developing type 2 diabetes is effective, according to a study led by Stanford University. The ongoing NHS Diabetes Prevention Program (DPP) was set up in 2016 and participants are adults who are at…

Heart health experts are declaring the overlapping effects of obesity, Type 2 diabetes, chronic kidney disease, and cardiovascular disease as a new syndrome—cardiovascular-kidney-metabolic syndrome, or CKM. This change, they say, is prompting rethinking of how they predict long-term cardiovascular risks. A presidential advisory from the American Heart Association (AHA), published Monday in the…

Researchers led by Hiroshi Ohno, MD, PhD, at Japan’s RIKEN Center for Integrative Medical Sciences have identified gut bacteria that reduces insulin resistance and may protect against type 2 diabetes and obesity. Their study, published today in Nature, involved analyzing human fecal microbiomes then corroborating their results with tests on…

Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have discovered that a metabolite found in urine predicts kidney failure from type 2 diabetes five to 10 years early. This new research, published in the Journal of Clinical Investigation, showed that adenine, a…